coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    East Waverley PCN, Waverley · Health Inequalities Profile

    PCN U94184 · NHS Surrey Heartlands Integrated Care Board; NHS Surrey and Sussex Integrated Care Board · 5 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    61,403

    Registered population

    55.7% aged 18–64

    23.2%

    Aged 65+

    ICB 18.8% · England 17.9%

    6.2%

    Ethnic minority (non-White)

    2.6% Asian · England 9.6%

    0.0%

    In IMD quintile 1

    ICB 0.8% · England 21.0%

    0

    Core20 residents (est.)

    Resident basis; registered basis 0 · see page 3

    9,667

    Hypertension register

    +5.11% in 3 yrs · England +5.60%

    503

    SMI register

    38.3% of Waverley's

    784

    COPD register

    Reviews +11.39% in 3 yrs

    Forecast to 2030

    11,269

    Hypertension patients, 2030

    +1,602 on today

    69.5%

    QRISK ≥20% on statins, 2030

    +6.39pp over 3 yrs

    6.7%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    57.5%
    Lipid therapy trails England across high-risk cohorts.

    CKD lipid-lowering therapy is 57.5% (England 70.3%) and QRISK ≥ 20% is 54.1% (England 63.6%), which may reflect unverified recall gaps.

    -18.6%
    Learning disability register fell; SMI checks trail.

    The 284-patient learning disability register fell by 18.6% over 2023 to 2025 (England +5.4%), while SMI blood pressure checks are 77.6% (England 83.4%).

    +12.8%
    Blood pressure control under 80 outpaced England.

    Control under 80 rose +12.8% over 2023 to 2025 (England +3.2%), and overall hypertension treatment to target rose +6.8 pp to 68.2%.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Older residents comprise 23.2% of registered patients, exceeding England by 5.3 percentage points

    East Waverley PCN serves 61,403 registered patients with an older age profile: 23.2% (14,267) are aged 65+, above Waverley (22.0%), NHS Surrey Heartlands Integrated Care Board (18.8%) and England (17.9%). Children aged 0-17 represent 21.1% (12,945). In associated Census areas, 93.8% of residents identify as White (Waverley 93.6%, ICB 85.3%, England 81.1%) and 2.6% as Asian (Waverley 2.8%, ICB 7.7%, England 9.6%). Projected list growth of 4.4% to 2030 (England 2.3%) may increase demand for complex chronic disease management, although the projection methodology remains unverified and Census ethnicity does not record patient-level registration.

    Age profile

    0–1721.1%
    18–6455.7%
    65+23.2%

    65+: ICB 18.8%, England 17.9%

    Ethnicity

    White93.8%
    Asian2.6%
    Mixed2.2%
    Other0.7%
    Black0.6%

    Older people · falls rows are Waverley local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Waverley LA)2,1642,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)82.7%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)62.2%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Waverley LA)9129819552024/25
    Falls deaths, all ages, per 100,000 (Waverley LA)9.614.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Average IMD decile is 8.3 with 0.0% of registered patients in Core20 areas

    East Waverley PCN has an average IMD decile of 8.3, compared with 8.5 in Waverley, 7.9 in NHS Surrey Heartlands Integrated Care Board, and 5.5 in England. Across all practices, 0.0% of registered patients live in Core20 areas, matching Waverley (0.0%) and below NHS Surrey Heartlands Integrated Care Board (0.8%) and England (21.0%), with 0 estimated resident patients in deciles 1 and 2. The absence of Core20 areas suggests health inequality initiatives could prioritize clinical risk registers and inclusion groups over area-based targeting.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Mill Medical0.0% · 0 patients
    Binscombe0.0% · 0 patients
    Wonersh0.0% · 0 patients
    Springfield0.0% · 0 patients
    Cranleigh Medical0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    503

    SMI register

    0.81% recorded prevalence

    284

    Learning disability register

    0.46% recorded prevalence

    26

    Care homes, 1,319 beds

    In the PCN catchment

    7.8%

    Provide unpaid care

    Waverley, Census 2021

    The PCN records 284 patients on the learning disability register (0.5%, England 0.6%) and 503 on the severe mental illness register (0.8%, England 1.0%), alongside 26 catchment care homes with 1,319 beds. At borough level, autumn 2025 snapshot data records 4 people sleeping rough, alongside an estimated PCN ceiling of 4,789 unpaid carers.

    Severe mental illness: physical health checks

    Across the 503-patient severe mental illness register (0.8% vs England 1.0%), blood pressure checks (77.6% vs 83.4%; Cranleigh Medical Practice 68.4%), BMI recording (77.6% vs 82.1%), and alcohol recording (69.9% vs 81.8%) trail England.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    9,667

    Hypertension register

    +5.11%

    Register growth, 3 yrs

    Waverley +6.01% · England +5.60%

    +7.28pp

    BP control, under 80

    ≤140/90 · +6.20pp aged 80+

    +1,602

    More patients by 2030

    Forecast 11,269 (17.28%)

    Hypertension case-finding and control

    Hypertension prevalence is 15.6% (9,667 patients), compared with Waverley (15.4%), NHS Surrey Heartlands Integrated Care Board (14.3%) and England (15.2%). Over 2023 to 2025, patients treated to target rose +6.8 pp (+11.0%, England +2.5 pp, +3.6%) to 68.2% (England 70.3%). However, blood pressure control among patients aged under 80 is 64.0%, trailing England (67.8%), Waverley (65.3%) and NHS Surrey Heartlands Integrated Care Board (68.1%). Recent blood pressure readings were recorded for 88.1% of patients (England 90.0%).

    Lipids and statins

    Lipid-lowering therapy coverage trails comparators across primary prevention: 54.1% for QRISK ≥ 20% (England 63.6%), 57.5% for chronic kidney disease (England 70.3%) and 65.7% for diabetes without CVD (England 73.2%).

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202674,325£2.40£2.24£1.86£178,380
    Cardiovascular (all), 2025116,690£5.59£4.74£3.33£652,297

    In 2026, lipid-regulating drugs cost £2.40 per item across 74,325 prescribed items (£178,380 spend), exceeding Waverley (£2.12), NHS Surrey Heartlands Integrated Care Board (£2.24) and England (£1.86), representing £40,136 more than at England's unit cost.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +10.99%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +2.86%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 7.0% (4,047 patients, England 6.6%), while 12-month review coverage is 60.5% (England 65.7%), leaving about 1,600 patients without a recorded review. For patients aged 6 to 19 with asthma, second-hand smoke recording is 71.8% (England 78.8%). COPD prevalence is 1.3% (784 patients, England 1.9%) with annual reviews at 74.1% (England 76.4%).

    Cancer register and children's immunisation

    The cancer register records 3,228 patients (5.2% vs England 3.8%). In Q1 2025/26, 6-in-1 coverage at 12 months was 93.5% and MMR dose 1 at 24 months was 93.6%, both below the 95.0% target. At age 5, MMR dose 2 reached 94.7%, trailing dose 1 (96.0%) by 1.3 pp.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months93.5%

    England 91.0%

    6-in-1 complete primary course at 24 months96.2%

    England 92.2%

    MMR dose 1 at 24 months93.6%

    England 88.3%

    MMR dose 2 at age 594.7%

    England 82.8%

    4-in-1 pre-school booster at age 596.0%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    61.4%

    Surrey Heartlands ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~650

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Surrey Heartlands ICBEnglandNo usable stageStaged cancers
    Prostate65.7%53.2%18%1,044
    Breast88.2%85.4%27%798
    Bowel48.1%47.0%18%626
    Lung33.2%33.8%17%497
    Skin cancer89.8%87.8%19%384

    In 2022, 61.4% of cancers with a known stage in NHS Surrey Heartlands ICB were diagnosed at stage 1 or 2 (2,955 of 4,810 staged cases), exceeding England's 55.3% but sitting 13.6 pp below the 75.0% national ambition by 2028, requiring about 650 extra early-stage diagnoses yearly (652.5). Staging completeness was 67.7% (4,810 of 7,106 registered cancers; England 67.0%). Early diagnosis was 88.2% for breast and 76.7% for cervix, but 48.1% for bowel and 33.2% for lung. At PCN level, cervical screening coverage is 73.9% (England 66.8%), while Cranleigh Medical Practice recorded 70.0% against Waverley's 73.8%.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026 (provisional), Royal Surrey NHS Foundation Trust met the 28-day faster diagnosis standard at 82.6% (standard 75.0%) and the 31-day combined standard at 96.4% (standard 96.0%). On the 62-day standard, Royal Surrey achieved 84.5%, sitting 0.5 pp below the 85.0% standard, while exceeding Frimley Health NHS Foundation Trust (81.8%), Ashford and St Peter's Hospitals NHS Foundation Trust (76.4%), NHS Surrey and Sussex Integrated Care Board (71.5%) and England (71.2%). In Jul 2026, Royal Surrey 6-week diagnostic waits were 0.0% for MRI, 0.1% for CT, 0.1% for non-obstetric ultrasound, and 38.5% for urodynamics.

    Pathways within standard (%)Royal SurreyFrimley HealthAshford and St Peter'sSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)82.6287.9585.5379.2979.32
    31-day treatment (96%)96.4392.8994.2190.4592.50
    62-day referral to treatment (85%)84.4881.8476.3871.5171.16
    Diagnostic waits over 6 weeks (%)Royal SurreyFrimley HealthAshford and St Peter'sEngland
    MRI0.0012.850.0921.40
    CT0.150.639.279.92
    Echocardiography1.553.350.9728.48
    Colonoscopy0.0022.8449.6130.83
    Gastroscopy0.007.4356.7429.02
    All 15 DM01 tests8.827.4923.1223.14
    Community services activitySurrey residentsSurrey and Sussex ICB
    Care contacts109,530309,615
    Referrals28,70066,930
    Patients with a contact33,51085,660

    Community services (residents of Surrey), Jun 2026 (provisional). In Jun 2026 (provisional), community health service activity recorded 109,530 contacts for Waverley residents, of which 76,215 (69.6%) were with adults aged 65+. These borough-level figures reflect wider system activity and are not available at PCN level.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Wonersh Surgery1310.075.7%77.6%91.8%
    Binscombe1040.062.2%67.7%88.3%
    Mill Medical960.070.1%88.3%84.1%
    Cranleigh Medical1060.075.5%71.2%80.2%
    Springfield1270.054.8%77.5%73.9%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNWaverleyAssetPCNWaverley
    Care homes (catchment)26 (1,319 beds)n/aSchools (catchment)79n/a
    Children's centres57Places of worship6795
    Libraries34Homelessness support (VCS)0no data
    Day centres (VCS)22Children and young people (VCS)11
    Carers support groups (VCS)11Primary schools (LA maintained)918
    Primary academies1217Special schools23

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Primary prevention lipid recall and review

    Lipid therapy is below England for CKD (57.5% vs 70.3%, difference -12.8 percentage points), QRISK ≥ 20% (54.1% vs 63.6%, difference -9.5 percentage points), diabetes without CVD (65.7% vs 73.2%, difference -7.4 percentage points) and with CVD (78.1% vs 84.4%, difference -6.3 percentage points); patient gap not sized. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    Learning disability register coding validation

    The 284-patient learning disability register (0.5% vs England 0.6%) fell 18.6% over 2023 to 2025 (England +5.4%), giving an unadjusted benchmark gap range of +38 to +77 across 61,403 patients. Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Option 3

    SMI physical health check outreach

    On the 503-patient SMI register (0.8% vs England 1.0%), annual BP checks are 77.6% (England 83.4%; Cranleigh Medical Practice 68.4%), BMI 77.6% (82.1%) and alcohol 69.9% (81.8%); gap not sized. Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older population capacity planning (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Systematic SMI physical health recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension control review (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school immunisation call-recall review (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Practice telephony and triage review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Primary prevention lipid recall and review (p12)Hypertension register · CKD patients treated with lipid lowering therapy · Patients with QRISK ≥ 20% treated with lipid lowering therapyCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 2 · Learning disability register coding validation (p12)Learning disability register · Learning disability: QOF prevalence · Registered population75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Option 3 · SMI physical health check outreach (p12)Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15